These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28614368)

  • 1. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
    Ho SC; Jacob SA; Tangiisuran B
    PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a cultural adaptation of pharmacotherapy: Latino views of depression and antidepressant therapy.
    Vargas SM; Cabassa LJ; Nicasio A; De La Cruz AA; Jackson E; Rosario M; Guarnaccia PJ; Lewis-Fernández R
    Transcult Psychiatry; 2015 Apr; 52(2):244-73. PubMed ID: 25736422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.
    Meng Y; Chiu C; Kapoor M; Li SA; Kaur N; Marr P; Kwan D; Leblanc K; Ji C; Papoushek C
    J Prim Care Community Health; 2024; 15():21501319241286313. PubMed ID: 39417387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What helps and what hinders antidepressant discontinuation? Qualitative analysis of patients' experiences and expectations.
    Meißner C; Meyrose AK; Nestoriuc Y
    Br J Gen Pract; 2024 Jul; 74(744):e466-e474. PubMed ID: 38228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
    Wu CH; Erickson SR; Piette JD; Balkrishnan R
    Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
    Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
    BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study on healthcare professionals' perceived barriers to insulin initiation in a multi-ethnic population.
    Lee YK; Lee PY; Ng CJ
    BMC Fam Pract; 2012 Jul; 13():28. PubMed ID: 22469132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers.
    Evon DM; Golin CE; Bonner JE; Grodensky C; Velloza J
    J Clin Gastroenterol; 2015; 49(5):e41-50. PubMed ID: 24828358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative Analysis of Barriers and Facilitators to Glaucoma Medication Adherence in a Randomized Controlled Trial Intervention.
    Rathinavelu JK; Muir KW; Majette NT; Woolson S; Olsen MK; Flaharty K; Newman-Casey PA; Kirshner M
    Ophthalmol Glaucoma; 2023; 6(6):626-635. PubMed ID: 37343624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.
    Ogedegbe G; Harrison M; Robbins L; Mancuso CA; Allegrante JP
    Ethn Dis; 2004; 14(1):3-12. PubMed ID: 15002917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare providers' perspectives on perceived barriers and facilitators of compassion: Results from a grounded theory study.
    Singh P; Raffin-Bouchal S; McClement S; Hack TF; Stajduhar K; Hagen NA; Sinnarajah A; Chochinov HM; Sinclair S
    J Clin Nurs; 2018 May; 27(9-10):2083-2097. PubMed ID: 29575539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
    Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
    BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes.
    Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA
    J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working with reactant patients: are we prescribing nonadherence?
    Madsen JW; McQuaid JR; Craighead WE
    Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care.
    Jamison J; Graffy J; Mullis R; Mant J; Sutton S
    Br J Gen Pract; 2016 Aug; 66(649):e568-76. PubMed ID: 27215572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Barriers to Glaucoma Treatment Adherence among Participants in South India.
    Killeen OJ; Pillai MR; Udayakumar B; Shroff S; Vimalanathan M; Cho J; Newman-Casey PA
    Ophthalmic Epidemiol; 2020 Jun; 27(3):200-208. PubMed ID: 31952462
    [No Abstract]   [Full Text] [Related]  

  • 20. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives.
    Onwuchuluba EE; Oyetunde OO; Soremekun RO
    J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.